Observational study / 2018
IgE sensitization to galactose-α-1,3-galactose was linked to higher atheroma volume and more unstable plaque features, especially in subjects ≤65 years old.
Researchers measured total IgE and specific IgE to galactose-α-1,3-galactose (α-Gal) in 118 subjects undergoing cardiac catheterization with intravascular ultrasound. IgE to α-Gal was detected in 26% of subjects, and atheroma burden was significantly higher in sensitized individuals (P=0.02). In participants ≤65 years of age, the association with atheroma burden was stronger (P<0.001), with plaques displaying less stable features. The association remained significant after adjusting for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; P=0.02), whereas IgE to inhalants and peanut showed no association with coronary artery disease.
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional observational study
- Who was studied
- 118 subjects presenting for cardiac catheterization who had intravascular ultrasound
- What was measured
- Atheroma burden and plaque stability characteristics
THE PAPER
IgE to the Mammalian Oligosaccharide Galactose-α-1,3-Galactose Is Associated With Increased Atheroma Volume and Plaques With Unstable Characteristics-Brief Report.
Wilson JM, Nguyen AT, Schuyler AJ, Commins SP, Taylor AM, Platts-Mills TAE, McNamara CA. Arterioscler Thromb Vasc Biol, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.